Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.93M Sell
57,419
-3
-0% -$328 1.17% 30
2026
Q1
$4.77M Buy
57,422
+8,491
+17% +$727K 0.87% 36
2025
Q4
$4.18M Sell
48,931
-7,391
-13% -$618K 0.8% 37
2025
Q3
$4.71M Buy
56,322
+17
+0% +$1.55K 0.85% 32
2025
Q2
$5.7M Buy
56,305
+26,901
+91% +$2.74M 1.13% 29
2025
Q1
$3.12M Buy
29,404
+4,525
+18% +$469K 0.72% 37
2024
Q4
$2.72M Sell
24,879
-2,586
-9% -$301K 0.59% 39
2024
Q3
$3.98M Buy
27,465
+525
+2% +$71.6K 0.89% 32
2024
Q2
$3.93M Buy
+26,940
New +$3.78M 0.95% 29

Other funds holding CROX

Kirr Marbach & Co's CROX Position: Q2 2026 in Review

Kirr Marbach & Co reduced its Crocs (CROX) stake by 0.01% in Q2 2026, selling an estimated $328 and leaving 57,419 shares worth $6.93M. The position accounts for 1.17% of the portfolio, ranked #30.

Kirr Marbach & Co first reported a position in CROX in Q2 2024 and has held it in 9 quarters since. 139 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

  • Kirr Marbach & Co held 57,419 shares of Crocs worth $6.93M as of Q2 2026.
  • Kirr Marbach & Co sold 3 Crocs shares in Q2 2026, an estimated $328.
  • Crocs made up 1.17% of Kirr Marbach & Co's portfolio in Q2 2026, its #30 holding.
  • Kirr Marbach & Co first reported a position in Crocs in Q2 2024 and has held it in 9 quarters since.
  • 139 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on Kirr Marbach & Co's 13F filing for Q2 2026, filed 14 Jul 2026.